Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, October 25, 2014
Technology Networks
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
Silencing the FOXP2 Speech Gene Causes Breast Cancer Cells to Metastasize
BIDMC investigators make the surprising discovery that a gene associated with speech and language is linked to advanced breast cancer.
Fast Modeling Of Cancer Mutations
New genome-editing technique enables rapid analysis of genes mutated in tumors.
New Test can Help Doctors Choose Best Treatment for Ovarian Cancer
ADNEX discriminate between benign and malignant tumours with a high level of accuracy.
All the Cell’s a Stage
Brian Strahl, PhD, and his band of biochemists unravel the complicated mysteries of the epigenetic code to find a culprit in cancer development.
New Cancer Drug To Begin Trials In Multiple Myeloma Patients
Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year.
ISB Gets $6.5 Million from NCI
Company has received two-year contract to create ‘Cancer Genomics Cloud’ with partners Google and SRA International.
Precise Control Over Genes Results from Game-Changing Research
UCSF invention greatly amplifies power of CRISPR technology.
Unusual Skin Cancer Linked To Chronic Allergy
Scientists have learned that inflammation at the site of an allergic skin rash can promote skin tumor formation if it persists.
New Clues For Early Colorectal Cancer Detection
Study identifies new biomarkers which could help detect colorectal cancer.
New 'Lab-on-a-Chip' Could Revolutionize Early Diagnosis of Cancer
Faster result times, reduced costs, minimal sample demands and better sensitivity of analysis.
Scroll Up
Scroll Down
Return
Non Viral Reagent for Efficient siRNA Delivery
Anne-Laure Bolcato-Bellemin, In vivo Research Manager, Polyplus-transfection, speaking at RNAi World Congress 2009
Date Posted: Monday, November 02, 2009
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



Polyplus-transfection Licenses Roche Glycart AG for PEI in vitro Transfection Applications for Research Purposes
Polyplus-transfection SA, a privately-held company developing innovative solutions for the delivery of nucleic acids in research, bioproduction and therapy, announced today that it has granted Roche Glycart AG, a Swiss biotechnology company fully-owned by Roche, a non exclusive license to use polyethylenimine (PEI) for in vitro transfection applications for research purposes.
Monday, January 24, 2011
Genethon to Use Polyplus-transfection’s jetPEI™ Transfection Reagent for Producing Viral Vectors
Genethon will use the jetPEI transfection reagent in the process of developing gene therapies for the treatment of rare diseases.
Friday, September 10, 2010
Polyplus-transfection Raises EUR 1.2 Million through an Issue of Convertible Bonds
New money will fund the company’s RNAplus research program and strengthen its human and material resources.
Friday, December 11, 2009
Polyplus-transfection Unveils Technology to Improve Intracellular Delivery of Small Interfering RNAs In-vivo
The "Sticky siRNA" technology is already being tested in vivo by academic laboratories and biotech companies.
Friday, April 25, 2008
 
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv